EpCAM EXPRESSION IN BREAST TUMOR CELLS AND THEIR RELATION TO CLINICAL AND PATHOLOGICAL PARAMETERS AND MOLECULAR SUBTYPE OF CANCER
Kovalevska L.M., Shlapatska L.M., Sidorenko S.P., Lukianova N.Yu., Kashuba E.V., Chekhun V.F.
Objective: to determine the features of EpCAM protein expression in samples of the breast cancer cells depending on the stage of the disease and the molecular subtype of the tumor. Object and method: specimens of the primary tumor in 35 patients with I–II stage of the breast cancer. Expression of EpCAM, Ki67, Her2/ neu, estrogen receptors (RE) and progesterone (RP) were determined by immunohistochemical method. EpCAM gene expression in samples of breast cancer was evaluated using Oncomine open-source bioinformatic analysis. Functional linkage analysis of the EpCAM protein was performed using a database and FunCoup algorithm. Statistical analysis was performed using GraphPadPrism7. Results: the highest (p = 0.0058) expression level of EpCAM protein was detected in cells of luminal A subtype of the breast cancer. Analysis of the samples grouped by stage showed an increase in the expression of EpCAM with disease progression (p = 0.0234). Analysis showed an inverse correlation between the expression level of EpCAM and the level of Ki67 proliferation marker: the lowest (p = 0.1088) expression of the latter was detected in the samples of the luminal A molecular subtype of the breast cancer. Conclusions: the highest (p = 0.0058) expression level of EpCAM protein was detected in cells of luminal A molecular subtype of the breast cancer. Analysis of the samples grouped by stage showed an increase in the expression of EpCAM with disease progression (p = 0.0234). The expression level of EpCAM shows an inverse correlation with the level of Ki67 proliferation marker: the lowest (p = 0.1088) expression of the latter was detected in the samples of the luminal A molecular subtype of the breast cancer.
No comments » Add comment